H

HRMY

HRMY

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
HRMY Live QuoteReal-time
$33.11
$5.59(-14.44%)1M
Day Range$32.73 – $33.40
Open$33.01
Previous Close$33.01
Volume565.8K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.94B
P/E Ratio (TTM)11.0
Forward P/E8.4
EPS (TTM)$3.02
Price to Book1.8
Dividend Yield0.65%
Beta (Volatility)0.98
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $33.11 (41%)
Low: $25.90High: $43.49
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$48.08-67.9% upside

Insider Buys

0

$0

Insider Sales

20

$290.98M

Total Volume

$290.98M

41 transactions

Net Activity

$290.98M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Marshman Fund Trust II

10%

0 buys1 sells

$139.39M total

V
2

Valor IV Pharma Holdings, LLC

10%

0 buys1 sells

$139.39M total

K
3

Kapadia Sandip

CFO

0 buys8 sells

$3.89M total

D
4

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

0 buys6 sells

$3.38M total

B
5

Budur Kumar

CHIEF MEDICAL OFFICER

0 buys2 sells

$3.11M total

Trading History
HRMY insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell13.1K$-38452.00$0

Sep 16, 2026

2 months ago

Budur Kumar

CHIEF MEDICAL OFFICER

C-Level
Sell38.5K$43.05$1.66M

Sep 4, 2026

2 months ago

Budur Kumar

CHIEF MEDICAL OFFICER

C-Level
Sell34.0K$42.80$1.45M

Sep 4, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell13.1K$-33954.00$0

Jan 26, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell24.5K$-3746.00$0

Jan 26, 2026

9 months ago

Kapadia Sandip

CFO

CFO
Sell3.7K$37.15$139K

Jan 15, 2026

10 months ago

Kapadia Sandip

CFO

CFO
Sell21.0K$35.92$753K

Jan 15, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell0$-20961.00$0

Dec 12, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-25933.00$0

Dec 12, 2025

11 months ago

Dayno Jeffrey M.

Pres, CEO

CEO
Sell25.9K$40.11$1.04M

Dec 5, 2025

11 months ago

Kapadia Sandip

CFO

CFO
Sell20.0K$39.54$791K

Dec 5, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Nov 21, 2025

12 months ago

Kapadia Sandip

CFO

CFO
Sell3.4K$35.00$120K

Nov 21, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell0$-3427.00$0

Aug 15, 2025

15 months ago

Kapadia Sandip

CFO

CFO
Sell21.6K$36.50$787K

Aug 15, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell0$-21573.00$0

Apr 1, 2025

19 months ago

Kapadia Sandip

CFO

CFO
Sell7.0K$32.54$227K

Apr 1, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell0$-6987.00$0

Mar 3, 2025

20 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell4.9K$32.67$159K

Mar 3, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4869.00$0

Jan 27, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-1775.00$0

Jan 24, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-14754.00$0

Jan 27, 2025

22 months ago

Kapadia Sandip

CFO

CFO
Sell1.8K$38.05$68K

Jan 24, 2025

22 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell14.8K$37.38$552K

Jan 21, 2025

22 months ago

Dayno Jeffrey M.

Pres, CEO

CEO
Sell19.3K$40.13$774K

Jan 21, 2025

22 months ago

Kapadia Sandip

CFO

CFO
Sell25.0K$40.18$1.00M

Jan 21, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-19293.00$0

Jan 16, 2025

22 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell30.6K$37.51$1.15M

Jan 16, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-30598.00$0

Jan 15, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-10507.00$0

Jan 15, 2025

22 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell10.5K$37.01$389K

Jan 13, 2025

22 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell7.2K$37.04$266K

Jan 13, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-7180.00$0

Nov 1, 2024

24 months ago

Marshman Fund Trust II

10%

10% Owner
Sell4.60M$30.30$139.39M

Nov 1, 2024

24 months ago

Valor IV Pharma Holdings, LLC

10%

10% Owner
Sell4.60M$30.30$139.39M

Nov 1, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell6.62M$-4600000.00$0

Oct 29, 2024

25 months ago

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

C-Level
Sell21.5K$40.47$870K

Oct 29, 2024

25 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-21496.00$0

Oct 1, 2024

25 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-400.00$0

Sep 30, 2024

26 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-35846.00$0

Sep 27, 2024

26 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-200.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
HRMY Buy Conviction0%
Industry Rank#0 of 563
Volume Contribution1.7%
Total Industry Activity$16.73B

HRMY has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for HRMY

Over the last 90 days, corporate insiders at HRMY (HRMY) engaged in a total of 41 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 20 were sales. The total volume of insider trading reached $290.98M.

The net insider activity for HRMY shows a net selling bias of $290.98M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Marshman Fund Trust II (10%), who traded 4.60M shares valued at $139.39M on Nov 1, 2024.

Live Market News & Developments
Aggregated real-time headlines for HRMY (HRMY)
6 updates

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts

Yahoo Finance13h ago

HRMY - Harmony Biosciences Holdings Inc Stock Price and Quote

Finviz176d ago

Harmony Bio CEO Plans His Exit, And Shares Take An Unharmonious Hit

Investor's Business Daily38d ago

There May Be Reason For Hope In Harmony Biosciences Holdings' (NASDAQ:HRMY) Disappointing Earnings

Simply Wall St3d ago

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

Yahoo Finance143d ago

symbol__ Stock Quote Price and Forecast

CNN1189d ago

FAQs About HRMY Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for HRMY.

Based on SEC Form 4 disclosures, the Insider Confidence Score for HRMY is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 20 sales by company executives over the last 90 days.

The CEO Conviction Index for HRMY is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.